# Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

> **NCT06965816** · — · COMPLETED · sponsor: **Centre Hospitalier de Saint-Denis** · enrollment: 85 (actual)

## Conditions studied

- Alzheimer's Disease
- Hippocampus
- Brain Atrophy
- Magnetic Resonance Imaging
- Leukoaraiosis
- Neurodegenerative Diseases
- Cortical and Subcortical Atrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06965816
- **Lead sponsor:** Centre Hospitalier de Saint-Denis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-24
- **Primary completion:** 2023-05-24
- **Final completion:** 2023-05-24
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06965816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06965816, "Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06965816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*